Dan I. Lubman

Turning Point, 
Melbourne, VIC, AU 
Turning Point, 
Melbourne, VIC, AU 

Overview

Dan Lubman practices practicing medicine in Melbourne, Australia.

His clinical expertise encompasses Delirium Tremens, Severe Acute Respiratory Syndrome (SARS), COVID-19, and ADULT Syndrome.

He is actively involved in clinical research, co-authoring 388 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Turning Point, Melbourne, VIC, Australia
Other Locations
Turning Point, Box Hill, VIC, Australia
Turning Point, Richmond, NSW, Australia
Turning Point, 110 Church Street, Richmond, VIC 3121, Australia
900 Dandenong Road, Caulfield East, VIC 3145, Australia
Level 2, 553 St Kilda Road, Melbourne, VIC 3004, Australia
5 Arnold St, Box Hill, VIC 3128, Australia
Turning Point, Clayton, QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Brief Intervention to Increase Knowledge of Alcohol as a Breast Cancer Risk Factor Among Women Attending Breast Screening Services (Health4Her): A Pilot Randomised Controlled Trial
A Brief Intervention to Increase Knowledge of Alcohol as a Breast Cancer Risk Factor Among Women Attending Breast Screening Services (Health4Her): A Pilot Randomised Controlled Trial
Enrollment Status: Completed
Publish Date: March 08, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable

388 Total Publications

MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.
MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress disorder and alcohol use disorder.
Journal: BMJ open
Published: July 06, 2026

Frequently Asked Questions about Dan I. Lubman

Is Dan I. Lubman a top-rated expert for Delirium Tremens?

MediFind is an objective health platform that identifies experts based on real-world data. Dan I. Lubman is classified as an Experienced expert for Delirium Tremens, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Dan I. Lubman participate in research or clinical trials?

Yes. Dan I. Lubman has published 388 articles and abstracts on conditions like Delirium Tremens. You can view a list of Dan I. Lubman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lubman's expertise for a condition
ConditionClose
        View All 10 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile